miscsubjectsAI governance
Evidence review

SS-31 (Elamipretide) for Nerve Damage: Mitochondrial Repair Pathways

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-nerve-damage`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-nerve-damage

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-nerve-damage/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-nerve-damage/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-nerve-damage/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-nerve-damage/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why SS-31 (Elamipretide) might help you

  1. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • SS-31 (Elamipretide) → mitochondrial

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Quantified confidence (this ledger): 0.37 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury (source s9)

2026 mouse SCI study with functional and histological outcomes.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Elamipretide alleviates pyroptosis in traumatically injured spinal cord by inhibiting cPLA2 (source s12)

Mechanistic SCI study linking SS-31 to autophagy and pyroptosis reduction.

Evidence type: Published research.

Elamipretide: A Review of Its Structure, Mechanism of Action... (source s0)

Review of mechanism.

Evidence type: Published research.

What people say on Reddit

My Experience Treating my ME/CFS with mitochondrial... — Reddit, r/cfs (source s24)

CFS user discussion on SS-31.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Nerve damage / repair · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 5 sources · swipe →chain ebe7d2457ebd · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
human
No published human clinical trials test SS-31 specifically for nerve damage or neuropathy.
humanlow confidence
Elamipretide received FDA approval for Barth syndrome based on TAZPOWER trial data showing muscle strength gains in open-label extension.
sources: s5
preclinicallow confidence
In a 2026 mouse contusive SCI model, SS-31 improved locomotor recovery, reduced lesion burden, preserved neurons, and attenuated early apoptosis markers.
sources: s9
mechanisticlow confidence
SS-31 binds cardiolipin on the inner mitochondrial membrane, stabilizing it against peroxidation and supporting ATP production under stress.
sources: s0
anecdotallow confidence
Reddit users in CFS/long COVID forums report trying SS-31 for energy and mitochondrial support, with mixed anecdotal outcomes including some autonomic symptom mentions.
sources: s24
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:51
SS-31 (Elamipretide) for Nerve Damage: Mitochondrial Repair Pathways · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Nerve Damage
Slug: ss-31-nerve-damage
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[
it output
{
  "slug": "ss-31-nerve-damage",
  "title": "SS-31 (Elamipretide) for Nerve Damage: Mitochondrial Repair Pathways",
  "body": "## What's breaking down\nNerve damage often starts with trauma, compression, inflammation, or metabolic stress that hits mitochondria first. Mitochondria supply ATP to axons and support structures. When they falter, reactive oxygen species rise, cardiolipin in the inner membrane oxidizes, and the permeability transition pore opens. This triggers apoptosis signals, swelling, and loss of neuronal integrity. Secondary cascades then expand the lesion: glial scarring forms, synaptic connections drop, and functional recovery stalls. In spinal cord injury models, contusion causes immediate mechanical disruption followed by mitochondrial collapse in surviving neurons. Similar patterns appear in optic nerve injury, traumatic brain injury, and inflammatory states that model aspects of neuropathy. The core issue is repair lagging behind ongoing degeneration at the mitochondrial layer.\n\n## Why SS-31 (Elamipretide) might help you\nSS-31 targets the inner mitochondrial membrane and binds cardiolipin. If mitochondrial dysfunction drives part of your nerve damage, this binding stabilizes the membrane, reduces electron leakage, and curbs ROS production. Step one: preserved cardiolipin keeps the electron transport chain efficient, so ATP output holds up instead of cra
4e1ada3171cb89db
Machine verification: /api/articles/ss-31-nerve-damage/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No published human clinical trials test SS-31 specifically for nerve damage or neuropathy."?
ask ss-31-nerve-damage claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "Elamipretide received FDA approval for Barth syndrome based on TAZPOWER trial data showing muscle strength gains in open-label extension."?
ask ss-31-nerve-damage claim c5 · paste includes §SELF
What does the ledger say about this (preclinical tier): "In a 2026 mouse contusive SCI model, SS-31 improved locomotor recovery, reduced lesion burden, preserved neurons, and attenuated early apopt…"?
ask ss-31-nerve-damage claim c1 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "SS-31 binds cardiolipin on the inner mitochondrial membrane, stabilizing it against peroxidation and supporting ATP production under stress."?
ask ss-31-nerve-damage claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users in CFS/long COVID forums report trying SS-31 for energy and mitochondrial support, with mixed anecdotal outcomes including some…"?
ask ss-31-nerve-damage claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "CFS user discussion on SS-31."
ask ss-31-nerve-damage source s24 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 (Elamipretide) for Nerve Damage: Mitochondrial Repair Pathways — and what would you need me to tell you first?
ask ss-31-nerve-damage condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 (Elamipretide) for Nerve Damage: Mitochondrial Repair Pathways (studies vs anecdotes)?
ask ss-31-nerve-damage good bad experiences · paste includes §SELF
ss-31-nerve-damage · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 43317 tokens · $0 · 2 models
chain head 35fe3bc5e25b14de
write grok/grok-4.3 · 2026-06-29 23:51 · 43317 tok · 0232cdbc259b
voxel_divide owner · 2026-07-17 02:42 · tokens unrecorded · 35fe3bc5e25b
verify chain →
Live ledger · 16 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 18:14
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 17:30
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 16:20
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 16:18
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 06:38
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 05:42
view full ledger & cards →
REST + ledger
read GET /api/articles/ss-31-nerve-damage · GET /api/articles/ss-31-nerve-damage?format=post (the editable body)
create/replace POST /api/articles/ss-31-nerve-damage · PUT /api/articles/ss-31-nerve-damage (replace, keeps revision) · PATCH /api/articles/ss-31-nerve-damage (merge)
delete DELETE /api/articles/ss-31-nerve-damage
writes need header x-terminal-key
LLM bundle GET /api/articles/ss-31-nerve-damage/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim ss-31-nerve-damage|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →